Heron Therapeutics Inc (HRTX)

Aug 20, 2025

Sector Rotation Brings Heron Therapeutics Inc. Into Focus2025 Winners & Losers & Accurate Entry/Exit Alerts - newsyoung.net

Aug 20, 2025

Aug 20, 2025

Technical Models Detect Momentum Build in Heron Therapeutics Inc.Weekly Trade Review & Fast Gain Swing Trade Alerts - classian.co.kr

Aug 20, 2025

Aug 20, 2025

Heron Therapeutics Inc. Stages Intraday Comeback — Trend Change2025 AllTime Highs & Trade Opportunity Analysis Reports - newsyoung.net

Aug 20, 2025

Aug 20, 2025

Heron Therapeutics (NASDAQ:HRTX) Stock Rating Upgraded by Zacks Research - MarketBeat

Aug 20, 2025

Aug 19, 2025

Heron Therapeutics Inc. Facing Inflection Point in Trend AnalysisJuly 2025 Patterns & Smart Investment Allocation Tips - newsyoung.net

Aug 19, 2025

Aug 18, 2025

Can Traders Expect Breakout From Heron Therapeutics Inc. This WeekJuly 2025 Chart Watch & Expert Approved Momentum Ideas - 선데이타임즈

Aug 18, 2025

Aug 18, 2025

XTX Topco Ltd Sells 213,080 Shares of Heron Therapeutics, Inc. $HRTX - MarketBeat

Aug 18, 2025

Aug 18, 2025

Adam Morgan Acquires 1,766,546 Shares of Heron Therapeutics, Inc. (NASDAQ:HRTX) Stock - MarketBeat

Aug 18, 2025

Aug 17, 2025

Heron Therapeutics Adopts Tax Benefit Preservation Plan - MSN

Aug 17, 2025

Aug 17, 2025

Informed Momentum Co LLC Takes $768,000 Position in Heron Therapeutics, Inc. (NASDAQ:HRTX) - MarketBeat

Aug 17, 2025

Aug 17, 2025

Tick level data insight on Heron Therapeutics Inc. volatilityMarket Growth Report & Technical Entry and Exit Alerts - Newser

Aug 17, 2025

Aug 17, 2025

Will Heron Therapeutics Inc. outperform the marketJuly 2025 PostEarnings & Weekly Market Pulse Alerts - Newser

Aug 17, 2025

Aug 17, 2025

Heron Therapeutics, Inc. (NASDAQ:HRTX) Major Shareholder Rubric Capital Management Lp Buys 2,387,225 Shares - MarketBeat

Aug 17, 2025

Aug 17, 2025

Heron Therapeutics Inc. stock trendline breakdownJuly 2025 Fed Impact & Consistent Profit Focused Trading Strategies - Newser

Aug 17, 2025

Aug 17, 2025

How to build a dashboard for Heron Therapeutics Inc. stockTrade Analysis Summary & Community Verified Swing Trade Signals - Newser

Aug 17, 2025

Aug 16, 2025

Is Heron Therapeutics Inc. undervalued by DCF analysisRecession Risk & Entry Point Confirmation Signals - newsyoung.net

Aug 16, 2025

Aug 16, 2025

Using portfolio simulators with Heron Therapeutics Inc. includedJuly 2025 Recap & Weekly Market Pulse Alerts - Newser

Aug 16, 2025

Aug 16, 2025

Heron Therapeutics Inc. stock volume spike explainedJuly 2025 Big Picture & AI Based Buy/Sell Signal Reports - Newser

Aug 16, 2025

Aug 16, 2025

Technical analysis overview for Heron Therapeutics Inc. stockPortfolio Value Report & Verified Chart Pattern Signals - Newser

Aug 16, 2025

Aug 16, 2025

Custom strategy builders for tracking Heron Therapeutics Inc.Quarterly Trade Summary & Long-Term Safe Return Strategies - Newser

Aug 16, 2025

Aug 15, 2025

Strategic Tax Preservation as a Catalyst for Long-Term Value Creation: Heron Therapeutics' Section 382 Rights Plan and Its Implications for Biotech Investors - AInvest

Aug 15, 2025

Aug 15, 2025

Heron Therapeutics Adopts Rights Plan to Protect Tax Benefits - MarketScreener

Aug 15, 2025

Aug 15, 2025

Heron Therapeutics adopts tax benefits preservation plan - TipRanks

Aug 15, 2025

Aug 15, 2025

Strategic Tax Planning as a Catalyst for Shareholder Value: Heron Therapeutics' Section 382 Rights Plan - AInvest

Aug 15, 2025

Aug 15, 2025

Heron Therapeutics adopts tax benefits plan to protect $1.37 billion in NOLs - Investing.com

Aug 15, 2025

Aug 15, 2025

$1.37 Billion Tax Asset Protection: Heron Therapeutics Adopts Strategic Rights Plan to Preserve NOLs - Stock Titan

Aug 15, 2025

Aug 15, 2025

Will Heron Therapeutics Inc. face regulatory challengesJuly 2025 Intraday Action & Safe Capital Investment Plans - newsyoung.net

Aug 15, 2025

Aug 14, 2025

Heron Therapeutics, Inc. (NASDAQ:HRTX) Q2 2025 Earnings Call Transcript - MSN

Aug 14, 2025

Aug 14, 2025

Heron Therapeutics (NASDAQ:HRTX) Announces Quarterly Earnings Results - MarketBeat

Aug 14, 2025

Aug 14, 2025

DLA Piper advises Heron Therapeutics in comprehensive capital financings - DLA Piper

Aug 14, 2025

Aug 14, 2025

Heron Therapeutics Signs Agreement with Patheon - MSN

Aug 14, 2025

Aug 14, 2025

Heron Therapeutics’ Earnings Call Highlights Growth and Strategy - TipRanks

Aug 14, 2025

Aug 14, 2025

Published on: 2025-08-14 05:28:34 - Newser

Aug 14, 2025

Aug 14, 2025

XTX Topco Ltd Sells 213,080 Shares of Heron Therapeutics, Inc. (NASDAQ:HRTX) - Defense World

Aug 14, 2025

Aug 13, 2025

Needham & Company LLC Cuts Heron Therapeutics (NASDAQ:HRTX) Price Target to $3.00 - MarketBeat

Aug 13, 2025

Aug 13, 2025

Heron Therapeutics Strengthens Financial Position with Refinancing - MSN

Aug 13, 2025

Aug 13, 2025

Heron Therapeutics (NASDAQ:HRTX) Lowered to Hold Rating by Wall Street Zen - MarketBeat

Aug 13, 2025

Aug 13, 2025

Warner Bros Discovery Director Buys $3.55M Worth of WBD Shares, Heron Therapeutics Director Purchases $2.65M Worth of HRTX Shares - AInvest

Aug 13, 2025

Aug 13, 2025

Heron Therapeutics Soars 13.74% on Insider Buying, Strategic Moves - AInvest

Aug 13, 2025

Aug 13, 2025

Rubric Capital and Director Morgan Make Significant Investments in Heron Therapeutics - AInvest

Aug 13, 2025

Aug 13, 2025

Heron Therapeutics Strengthens Financial Position with Refinancing and Board Changes - AInvest

Aug 13, 2025